The Federal Trade Commission accuses CVS, Cigna and UnitedHealth of artificially inflating prices on specialty generic drugs ...

The markups helped the PBMs reap $7.3 billion from 2017 to 2022, the FTC found. The PBMs—owned by insurers Cigna, CVS Health and UnitedHealth Group—are supposed to help keep drug costs low for ...

The U.S. Federal Trade Commission on Tuesday published the second part of its investigation into how prescription drug ...

Columbus City Attorney Zach Klein announced that the city has filed a lawsuit against several drug companies and pharmacy ...

Voters in blue cities have to watch the conflagration in Los Angeles and realize that they get what they vote for.

T]he sentence was, in the words of the New York Times, ‘rare and lenient.’ But that does not mean Trump has not been punished in the case. The truth is the opposite. Trump paid a serious price in time ...